Cantargia AB
STO:CANTA

Watchlist Manager
Cantargia AB Logo
Cantargia AB
STO:CANTA
Watchlist
Price: 1.812 SEK -2.42% Market Closed
Market Cap: 332.8m SEK
Have any thoughts about
Cantargia AB?
Write Note

Cantargia AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cantargia AB
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Cantargia AB
STO:CANTA
Operating Expenses
-kr199m
CAGR 3-Years
15%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Operating Expenses
-kr508.9m
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Operating Expenses
-kr658.5m
CAGR 3-Years
-35%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Operating Expenses
-kr5.6B
CAGR 3-Years
-131%
CAGR 5-Years
-66%
CAGR 10-Years
-39%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Operating Expenses
-kr14B
CAGR 3-Years
-23%
CAGR 5-Years
-21%
CAGR 10-Years
-23%
BioArctic AB
STO:BIOA B
Operating Expenses
-kr300.5m
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
No Stocks Found

Cantargia AB
Glance View

Market Cap
332.8m SEK
Industry
Biotechnology

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. The company is headquartered in Lund, Skane. The company went IPO on 2015-03-17. The firm is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

CANTA Intrinsic Value
1.024 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cantargia AB's Operating Expenses?
Operating Expenses
-199m SEK

Based on the financial report for Sep 30, 2024, Cantargia AB's Operating Expenses amounts to -199m SEK.

What is Cantargia AB's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-14%

Over the last year, the Operating Expenses growth was 36%. The average annual Operating Expenses growth rates for Cantargia AB have been 15% over the past three years , -14% over the past five years .

Back to Top